Skip to main content

David Kereiakes is a Partner for Providence Ventures, where he has helped lead the formulation of the firm’s medical device investment strategy.  David also supports investment strategy and decision processes in software and service focused businesses.

David previously worked for River Cities Capital Fund (RCCF), one of the most active and experienced growth equity funds in healthcare and information technology. David most recently was a Principal on the healthcare team having served on deal teams across medical devices, software, and services. David also served as President and Board Member of Mid-America Health Investors Network (MHIN), where he represented over 60 active healthcare funds with offices spread throughout Middle America.

David currently or previously served as a Board Director, Board Observer, or co-led financings for TailorMed, MacroHealth, OrthAlign Inc., AVIA Health, NICO Corp., Wildflower Health, Bolder Surgical (acquired by Hologic), Veran Medical (acquired by Olympus), TissueTech (sold to financial sponsor), and Advanced Practice Strategies (acquired by Relias Learning).

David graduated from Indiana University’s Kelley School of Business and received his MBA with a concentration in finance from Xavier University’s Williams College of Business.